Drug Screening
iPSC-Derived Cells
Our state-of-the-art platform leverages iPSC-derived cells to revolutionize the drug discovery and development process, offering unparalleled precision, efficiency, and relevance.
Why iPSC?
Human Relevance
iPSCs can ensure that the cells used in our drug screening processes are genetically and functionally similar to human tissues, providing more accurate and predictive results compared to traditional animal models.
Disease Modelling
iPSCs can be generated from patients with specific genetic conditions, enabling the creation of disease-specific cell models. These models allow us to identify potential therapeutic targets with greater precision.
High-Throughput Screening
Our technology integrates iPSC-derived cells with high-throughput screening platforms. This combination accelerates the identification of promising drug candidates, reducing the time and cost associated with drug development
Applications
01
Endothelial Cell Testing
02
Cardiotoxicity Testing
03
Neurotoxicity Testing
Our Technology Platform
Advanced Differentiation Protocols
Automated High-Throughput Screening
Data Analytics and AI Integration
